SCHEMBL21149673

SCHEMBL21149673

CC(C)OC(=O)N1CCC1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.37
TSHR P16473 2/20 0.36
P2RX4 Q99571 1/20 0.34
BCHE P06276 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
GPR119 Q8TDV5 2/20 0.33
RAB9A P51151 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.32
HCRTR2 O43614 1/20 0.32
HSD11B1 P28845 1/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NR1H2 P55055 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12787401 0.89 GAA (0.42) DPP4GAAHPGDRAB9AALDH1A1
SCHEMBL5821651 0.87 HPGD (0.49) TSHRSMN1; SMN2GAAHPGDALDH1A1
SCHEMBL22653904 0.78 DPP4 (0.36) DPP4TSHRP2RX4BCHEGPR119
SCHEMBL1631699 0.77
SCHEMBL23854152 0.77
SCHEMBL19785906 0.77 DPP4 (0.38) DPP4TSHRALDH1A1HCRTR2KDM4E
SCHEMBL15258053 0.77 DPP4 (0.38) DPP4TSHRALDH1A1HCRTR2KDM4E
Hydrochloric Acid SCHEMBL15254308 0.75 DPP4 (0.38) DPP4TSHRSMN1; SMN2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL29613587 0.75 DPP4 (0.38) DPP4TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL16468333 0.75 PHGDH (0.40) DPP4TSHRP2RX4BCHESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10774053-B2 HIV protease inhibitors GILEAD SCIENCES, INC. (US) 2020-09-15 US disclosed
US-20190210978-A1 HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10774053-B2 HIV protease inhibitors PRSS1, SERPINB1, FURIN DPP4 103/4885TSHR 4797/4885P2RX4 4360/4885
US-20190210978-A1 HIV PROTEASE INHIBITORS PRSS1, SERPINB1, HPN DPP4 139/4885TSHR 4832/4885P2RX4 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.